Fidelity Disruptive Medicine ETF (FMED)
The ETF invests in disruptive medicine companies that exhibit innovative developments with the goal of outperforming incumbents in the long run.
ETF Info
| Issuer | Fidelity |
|---|---|
| Inception Date | Apr 16, 2020 |
| Category | Health & Biotech Equities |
| Index Tracked | No Index (Active) |
| Home Page | institutional.fidelity.com |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Growth |
Expense Ratio
FMED has a high expense ratio of 0.50%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: FMED vs. FDHT
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Fidelity Disruptive Medicine ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 0.04% | 9.49% |
| 1 month | -2.73% | 1.20% |
| 6 months | 19.70% | 18.29% |
| 1 year | N/A | 26.44% |
| 5 years (annualized) | N/A | 12.64% |
| 10 years (annualized) | N/A | 10.67% |
Monthly Returns
The table below presents the monthly returns of FMED, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.36% | 4.22% | 1.47% | -6.39% | 0.04% | ||||||||
| 2023 | -0.71% | 1.07% | -5.91% | -7.29% | -8.41% | 6.12% | 12.59% | -4.20% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Not enough dataDividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Disruptive Medicine ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Disruptive Medicine ETF was 21.84%, occurring on Oct 30, 2023. Recovery took 81 trading sessions.
The current Fidelity Disruptive Medicine ETF drawdown is 5.38%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -21.84% | Jul 24, 2023 | 70 | Oct 30, 2023 | 81 | Feb 27, 2024 | 151 |
| -8.2% | Feb 28, 2024 | 37 | Apr 19, 2024 | — | — | — |
| -4.36% | Jun 14, 2023 | 16 | Jul 7, 2023 | 10 | Jul 21, 2023 | 26 |
Volatility
Volatility Chart
The current Fidelity Disruptive Medicine ETF volatility is 5.19%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.